Please login to the form below

Not currently logged in
Email:
Password:

NHS to roll out brain laser therapy for epilepsy patients

There are around 600,000 people living with epilepsy across the UK

NHS

The NHS has announced its plans to launch an innovative laser therapy – known as laser interstitial thermal therapy (LITT) – for those diagnosed with epilepsy, who have not previously responded well to other therapies.

The first surgeries are set to take place in early 2023 and potentially benefit up to 150 NHS patients each year, offering hope to thousands of people living with the condition.

The fibre optic laser requires a 1.5mm-wide probe into the skull and destroys the brain tissue which causes epilepsy from the inside by using heat.

The treatment uses an MRI scanner and the specialist clinical team carefully navigates through the brain, avoiding blood vessels and other critical structures, while also monitoring the temperature of the surrounding areas to ensure healthy brain tissue does not overheat.

For those undergoing the treatment, the small wound heals quickly, which allows patients to go home the next day with minimal risk of infection or other side effects.

The launch of the laser is the latest result of the NHS’s Long Term Plan commitment, ensuring patients across the country are able to access the latest treatments available.

NHS national medical director Professor Sir Stephen Powis said: “This pioneering laser beam treatment for epilepsy patients is life-changing and will offer hope to hundreds of people every year who have not had success in preventing seizures with traditional drugs.

“By replacing invasive neurosurgery with a cutting-edge laser therapy, allowing clinicians to better target the parts of the brain causing the epilepsy, we not only dramatically reduce risks to these patients, but drastically reduce their recovery time both in and out of hospital.

“The treatment is yet another example of how the NHS continues to deliver on its NHS Long Term Plan commitment to secure the latest medical innovations for patients while also using our commercial means to ensure value for money.”

Approximately 600,000 people live with the condition across the UK, and one in three people with epilepsy are unable to control their seizures with drugs alone and may need invasive neurosurgery to remove the epilepsy-causing part of the brain.

NHS medical director for specialised services Professor James Palmer said: “This innovative laser therapy is a game-changing breakthrough for patients who have not had success with traditional forms of treatment to control their seizures and will give those with epilepsy a real chance to live a normal life.

“The NHS is committed to rolling out cutting-edge treatments as quickly as possible – it is just one of seven new innovations that the NHS is making available to patients from today across the country following the latest review of treatments and technologies that should be prioritised for investment.”

Article by
Fleur Jeffries

24th October 2022

From: Healthcare

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
foxandcat.online

We help communications teams to thrive under pressure. Here at fox&cat, we help all kinds of teams to fight all...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...